Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AMP Health vs TeleHealth Med

AMP Health
Graded #200

Level

vs
TeleHealth Med
Graded #209

Level

The verdict

Too close to call — both grade 66.1/100 (C).

AMP Health and TeleHealth Med land on the same WeighScore, so neither clears the other on our six graded dimensions. AMP Health sits one line higher on the board (#200 vs #209) on the underlying tiebreak, but it's a genuine coin-flip — pick on the factors and prices that matter most to you below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTeleHealth Med +14
60
74
Dose & formulationAMP Health +25
88
63
Clinical oversightTeleHealth Med +1
75
76
Labs & monitoringEven
52
52
FulfillmentTeleHealth Med +1
62
63
Contract termsTeleHealth Med +14
41
55
AMP Health · left barTeleHealth Med · right bar

The numbers

MetricAMP HealthTeleHealth Med
WeighScore66.1/10066.1/100
GradeCC
Scorecard rank#200#209
Semaglutide$199/mo (compounded)$147/mo (starting dose, compounded)
Tirzepatide$309/mo (compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesYes
AMP Health

Graded #200 · C

Strengths

  • Semaglutide in both injectable and oral formats
  • Tirzepatide available
  • 30-day satisfaction guarantee
  • Personal nutrition plan and health coaching included

Where it loses points

  • $79/mo subscription fee on top of medication ($278–$388/mo total)
  • No visible LegitScript or PCAB accreditation
  • No physical address disclosed
  • States served not disclosed
  • Brand Wegovy listed but out of stock
TeleHealth Med

Graded #209 · C

Strengths

  • Corporate entity disclosed (TeleHealth Med, Inc.) — clearer accountability than undisclosed competitors
  • Publishes the FDA compounded-medication disclaimer
  • 503A pharmacy designation stated in the FAQ
  • Honest disclosure that testimonials are compensated and results aren't independently verified
  • Both injectable and sublingual forms offered

Where it loses points

  • Specific 503A pharmacy partner not named
  • LegitScript ID number not shown in text — only a verification link
  • Full states-served list not disclosed
  • Named medical director not disclosed
  • Dose tiers beyond the $147/mo starting price not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard